According to Amphastar Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 47,957,000. At the end of 2023 the company had 47,957,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 47.95 M | -0.71% |
2022 | 48.29 M | 0.97% |
2021 | 47.83 M | 0.72% |
2020 | 47.49 M | 1.4% |
2019 | 46.84 M | 1.24% |
2018 | 46.26 M | 0.08% |
2017 | 46.23 M | 0.28% |
2016 | 46.1 M | 1.75% |
2015 | 45.31 M | 1.48% |
2014 | 44.64 M | 458.1% |
2013 | 8 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Tonix Pharmaceuticals TNXP | 15,327,558 | -68.04% | ๐บ๐ธ USA |
SCYNEXIS SCYX | 47,891,996 | -0.14% | ๐บ๐ธ USA |
Marinus Pharmaceuticals MRNS | 53,920,109 | 12.43% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | 2,950,136 | -93.85% | ๐บ๐ธ USA |